Dr. Randy L. Levine, MD

Dr. Levine practices at Lenox Hill Hospital in New York, New York, part of Northwell Health.

Dr. Levine's NPI, 1700986247, was assigned on September 24, 2006. Dr. Levine graduated from Jacobs School of Medicine and Biomedical Sciences in 1979. Dr. Levine's New York license number on file is 145824.

Dr. Levine's primary practice is Lenox Hill Hospital, at 100 East 77th Street, New York, NY 10075 in New York County. The practice phone is (212) 434-2000.

Dr. Levine's primary practice is Lenox Hill Hospital in New York, New York, part of Northwell Health. The medical group on file is Northwell Health Physician Partners Cardiology at Great Neck. Dmand AI also links Dr. Levine to 1 more physician office, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Levine practices, 2 sites in all. Vendor and product names are available with a free account.

Internal medicine is Dr. Levine's primary specialty in the NPI Registry, under taxonomy code 207RH0000X. The record also lists hematology. Dr. Levine is board certified in hematology by the American Board of Internal Medicine. Dmand AI has Dr. Levine's licenses on file in 3 states: New York, Florida and New Jersey.

Dmand AI lists acute skin infection, atrial fibrillation and flutter, chronic anemia, chronic diabetes, chronic hypertension, coronary artery disease, deep vein thrombosis (DVT) and gastrointestinal bleeding among the conditions Dr. Levine treats.

CMS data shows 819 Medicare services from Dr. Levine across 6 procedure codes in 2024, for 379 Medicare patients. Medicare paid $72,538 for them.

CMS counts 379 Medicare patients who saw Dr. Levine in 2024. The largest group is 75 to 84, with 178 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 12% are also on Medicaid. Their average risk score is 1.79, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Levine's median patient age at 46, with 68% women.

In 2024, Dr. Levine wrote 457 Medicare Part D claims for 74 patients. 58% of them were for generic drugs. CMS names the drug for 310 of them, across 15 drugs with 11 or more claims each, at $1,208,704 in total drug cost. In 2023, CMS named 312 claims across 16 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 93 out of 100 for Dr. Levine for performance year 2024, reported through an alternative payment model (APM). Dr. Levine accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Levine as offering telehealth.

Dmand AI links 7 papers to Dr. Levine, published from 2012 to 2023. 2022 was the busiest year, with 2. The most frequent topics are Postoperative Hemorrhage, Factor V and Factor V Deficiency. Dr. Levine's most frequent co-authors are Derek R. Brinster, MD, Jerry Jacob George, DO and Jonathan Mishali Hemli, MD.

Dmand AI links Dr. Levine to 1 clinical trial. Conditions studied include Leukemia, Myeloid, Acute and Leukemia, Myeloid.

CMS Open Payments shows 14 general payments to Dr. Levine from 4 drug and device companies from 2017 to 2020. Food and beverage make up the largest share, 100% of the total. Pfizer Inc. paid the most, $104.

Dmand AI lists 3 awards for Dr. Levine, most recently New York Magazine: Top Doctors in 2014.

Dr. Levine graduated from Jacobs School of Medicine and Biomedical Sciences in 1979.

Dr. Levine is in network with 7 carriers, including Aetna, Blue Cross Blue Shield of Massachusetts and Cigna. Medicare plans come from the most carriers, 6. Check the plan with the practice before a visit.